Gary Bridger
CIK 1600049 · EVP, Research & Development · last filed 2026-01-07
Gary Bridger is an EVP, Research & Development who has filed 20 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for XFOR, was dated Jan 7, 2026. Current disclosed insider exposure totals $18.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.9K
4
20
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XFOR | Director | 4,722 | $4.00 | $18.9K | $0 | 10 | 2026-01-07 |
| Neurogene Inc. (AQXP) Delisted | Director | 0 | — | — | $0 | 7 | 2018-05-09 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Director | 0 | — | — | $0 | 2 | 2015-11-03 |
| XENE | EVP, Research & Development | — | $52.10 | — | $0 | 1 | 2014-11-25 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2025-06-10 | XFOR | Grant (A) | +1,500 | $0 | EDGAR |
| 2024-06-11 | XFOR | Grant (A) | +45,000 | $0 | EDGAR |
| 2023-06-14 | XFOR | Grant (A) | +45,000 | $0 | EDGAR |
| 2022-06-27 | XFOR | Grant (A) | +6,667 | $0 | EDGAR |
| 2021-06-02 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2020-10-06 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2019-04-02 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2019-03-14 | XFOR | Grant (A) | — | $0 | EDGAR |